Literature DB >> 24659657

Neuron specific enolase and prognosis of non-small cell lung cancer: a systematic review and meta-analysis.

Hai-Jun Yan1, Yan Tan, Wei Gu.   

Abstract

PURPOSE: The predictive and prognostic role of neuron-specific enolase (NSE) in non-small cell lung cancer (NSCLC) is still under debate. The present meta-analysis aimed to evaluate the relation between serum NSE levels and the prognosis of NSCLC.
METHODS: We performed a meta-analysis of published studies assessing the association of NSE with the prognosis of NSCLC. Literature retrieval, trials' selection and assessment, data collection, and statistical analysis were performed according to the Revman 5.0 guidelines. A fixed-effect model was used to pool the hazard ratio (HR) and 95% confidence intervals (95% CIs).
RESULTS: A total of 8 eligible studies that included 2389 NSCLC patients were analyzed. We did not find prognostic value of NSE for NSCLC (HR=1.17, 95% CI: 0.95-1.44, p=0.14).
CONCLUSION: The present study indicated that serum NSE level is of no prognostic significance in patients with NSCLC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24659657

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  8 in total

Review 1.  History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer.

Authors:  Haruhiko Nakamura; Toshihide Nishimura
Journal:  Surg Today       Date:  2017-02-22       Impact factor: 2.549

2.  Value of serum marker HE4 in pulmonary carcinoma diagnosis.

Authors:  Qin-Fang Tang; Zhong-Wei Zhou; Hong-Bing Ji; Wu-Hua Pan; Ming-Zhong Sun
Journal:  Int J Clin Exp Med       Date:  2015-10-15

3.  The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients.

Authors:  M G Dal Bello; R A Filiberti; A Alama; A M Orengo; M Mussap; S Coco; I Vanni; S Boccardo; E Rijavec; C Genova; F Biello; G Barletta; G Rossi; M Tagliamento; C Maggioni; F Grossi
Journal:  J Transl Med       Date:  2019-03-08       Impact factor: 5.531

4.  Knockdown of neuron-specific enolase suppresses the proliferation and migration of NCI-H209 cells.

Authors:  Xia Liu; Shousheng Liu; Juan Fu; Jinsheng Huang; Chengyin Weng; Xisheng Fang; Mingmei Guan; Yong Wu; Lin Yang; Guolong Liu
Journal:  Oncol Lett       Date:  2019-09-04       Impact factor: 2.967

5.  Multifunctional neuron-specific enolase: its role in lung diseases.

Authors:  Cai-Ming Xu; Ya-Lan Luo; Shuai Li; Zhao-Xia Li; Liu Jiang; Gui-Xin Zhang; Lawrence Owusu; Hai-Long Chen
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

6.  Comparison of Serum MicroRNA21 and Tumor Markers in Diagnosis of Early Non-Small Cell Lung Cancer.

Authors:  Mingzhong Sun; Jiangxiang Song; Zhongwei Zhou; Rong Zhu; Hao Jin; Yuqiao Ji; Qiang Lu; Huixiang Ju
Journal:  Dis Markers       Date:  2016-01-11       Impact factor: 3.434

7.  Predictive and prognostic value of preoperative serum tumor markers in resectable adenosqamous lung carcinoma.

Authors:  Qiongjie Zhi; Yuqian Wang; Xinyue Wang; Dongsheng Yue; Kai Li; Richeng Jiang
Journal:  Oncotarget       Date:  2016-10-04

8.  The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types.

Authors:  Haiqing Chen; Fangqiu Fu; Yue Zhao; Haoxuan Wu; Hong Hu; Yihua Sun; Yawei Zhang; Jiaqing Xiang; Yang Zhang
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.